6230 articles
Rare genetic syndrome caused by TP53 mutations leads to extraordinarily high lifetime cancer risk, with new prevention strategies emerging.
UK biotech secures major funding for antibody therapy targeting protein buildup that damages hearts in amyloidosis patients.
Women who experience spontaneous coronary artery dissection during pregnancy face worse heart damage and slower recovery than non-pregnant cases.
New research reveals how missing CD40 protein leads to severe lung blood clots when combined with heart failure conditions.
Scientists discover how beneficial gut bacteria produce proteins that bind to inflammatory toxins, potentially reducing chronic inflammation.
Dr. Jack Feldman reveals how specific breathing techniques reduce anxiety and enhance cognitive performance through neural mechanisms.
New regenerative therapy combines platelet-rich plasma with biomaterial scaffolds to enhance wound repair through multiple healing pathways.
Revolutionary blood tests can detect cancer DNA fragments, enabling earlier diagnosis and better treatment monitoring.
Women with RA using treat-to-target therapy achieved pregnancy 3x faster than those with standard care, with 77% conceiving within one year.
Malondialdehyde levels in blood can predict which heart failure patients are most likely to die, offering early warning signs.
New review reveals how tiny cellular particles could transform alopecia treatment with better safety and effectiveness than current options.
New research reveals how a naturalized gut microbiome teams up with dietary fiber to protect against harmful colon inflammation.
